Literature DB >> 17956594

Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.

Martin Offterdinger1, Philippe I Bastiaens.   

Abstract

We have analyzed the spatial-temporal regulation of epidermal growth factor receptor (EGFR) phosphorylation by the orphan erbB2 receptor. It is shown that EGFR association with erbB2 is sufficient to prolong and enhance the net phosphorylation of EGFR, independent of the kinase activity of erbB2. This enhanced EGFR signaling was rather caused by erbB2-mediated retention of phosphorylated EGFR at the plasma membrane (PM), thereby preventing EGFR dephosphorylation and signal termination by endomembrane-bound protein tyrosine phosphatases (PTPs). EGF-induced EGFR internalization was indeed blocked in the presence of high levels of erbB2 or if cbl binding of EGFR was impaired. This erbB2-mediated blockage of the entry of activated EGFR into clathrin-coated vesicles could be alleviated by antibody-mediated disruption of the interaction between EGFR and erbB2. These results identify erbB2-mediated dominant trapping of phosphorylated EGFR at the PM as a mechanism that prolongs EGFR signaling, by sequestration of activated EGFR away from intracellular sites of high PTP activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956594     DOI: 10.1111/j.1600-0854.2007.00665.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  25 in total

1.  Single-Cell Intravital Microscopy of Trastuzumab Quantifies Heterogeneous in vivo Kinetics.

Authors:  Ran Li; Adel Attari; Mark Prytyskach; Michelle A Garlin; Ralph Weissleder; Miles A Miller
Journal:  Cytometry A       Date:  2019-08-19       Impact factor: 4.355

2.  The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.

Authors:  Xiangdong Zhou; Yehenew M Agazie
Journal:  Cell Signal       Date:  2011-09-03       Impact factor: 4.315

3.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

4.  Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.

Authors:  Yu Li; Jennifer Macdonald-Obermann; Corey Westfall; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 5.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

6.  Systems biological analysis of epidermal growth factor receptor internalization dynamics for altered receptor levels.

Authors:  Hannah Schmidt-Glenewinkel; Eileen Reinz; Roland Eils; Nathan R Brady
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

7.  Ligand Density and Nanoparticle Clustering Cooperate in the Multivalent Amplification of Epidermal Growth Factor Receptor Activation.

Authors:  Qianyun Zhang; Björn M Reinhard
Journal:  ACS Nano       Date:  2018-10-11       Impact factor: 15.881

Review 8.  HER2-positive male breast cancer: an update.

Authors:  Laura Ottini; Carlo Capalbo; Piera Rizzolo; Valentina Silvestri; Giuseppe Bronte; Sergio Rizzo; Antonio Russo
Journal:  Breast Cancer (Dove Med Press)       Date:  2010-10-04

9.  Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.

Authors:  Byung Min Chung; Srikumar M Raja; Robert J Clubb; Chun Tu; Manju George; Vimla Band; Hamid Band
Journal:  BMC Cell Biol       Date:  2009-11-30       Impact factor: 4.241

Review 10.  The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Authors:  Muireann T Kelleher; Gilbert Fruhwirth; Gargi Patel; Enyinnaya Ofo; Frederic Festy; Paul R Barber; Simon M Ameer-Beg; Borivoj Vojnovic; Cheryl Gillett; Anthony Coolen; György Kéri; Paul A Ellis; Tony Ng
Journal:  Target Oncol       Date:  2009-09-16       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.